Form 4: Lemaitre Vascular Director Acquires Shares Through Vesting

Lemaitre Vascular Director John A. Roush acquired 10 shares of common stock through the release of dividend equivalent rights from previously granted equity awards.

Summary

• Director John A. Roush acquired a total of 10 shares of Lemaitre Vascular Inc. common stock on December 12, 2025.
• The shares were acquired upon the release of dividend equivalent rights (DERs) associated with a restricted stock unit (RSU) award and a performance stock unit (PSU) award, both granted on December 12, 2022.
• Each DER was the economic equivalent of one share of common stock, and the acquisition price was $0 per share.
• Following these transactions, Mr. Roush directly beneficially owns 3,465 shares of common stock.
• Additionally, Mr. Roush indirectly beneficially owns 181 shares of common stock through his spouse.
• All dividend equivalent rights were released, resulting in a zero balance for derivative securities after the transactions, with any fractional shares settled in cash.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction related to equity compensation vesting. While not a direct market purchase, it increases insider ownership, which is generally viewed as a neutral to slightly positive signal, indicating continued alignment of interests.

Positives

• The acquisition of shares, even through vesting, increases the director's direct beneficial ownership in the company to 3,465 shares, aligning insider interests with shareholders.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction related to equity compensation and does not provide broader industry context or trends.

Stakeholder Impact

• Shareholders: The increase in director's beneficial ownership aligns management's interests with those of shareholders, potentially fostering long-term value creation.

Key Dates

Keywords

LEMAITRE VASCULAR, LMAT, Form 4, Insider Transaction, Stock Acquisition, Director, Common Stock, Dividend Equivalent Rights, RSU, PSU, Equity Compensation